195 related articles for article (PubMed ID: 10779084)
1. Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences.
John S; Schmieder RE
J Hypertens; 2000 Apr; 18(4):363-74. PubMed ID: 10779084
[TBL] [Abstract][Full Text] [Related]
2. Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia.
John S; Schmieder RE
Curr Hypertens Rep; 2003 Jun; 5(3):199-207. PubMed ID: 12724051
[TBL] [Abstract][Full Text] [Related]
3. Hypercholesterolemia and Hypertension: Two Sides of the Same Coin.
Ivanovic B; Tadic M
Am J Cardiovasc Drugs; 2015 Dec; 15(6):403-14. PubMed ID: 26062915
[TBL] [Abstract][Full Text] [Related]
4. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options.
Britten MB; Zeiher AM; Schächinger V
J Intern Med; 1999 Apr; 245(4):315-27. PubMed ID: 10356593
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension.
Li Q; Youn JY; Cai H
J Hypertens; 2015 Jun; 33(6):1128-36. PubMed ID: 25882860
[TBL] [Abstract][Full Text] [Related]
6. Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks.
John S; Delles C; Jacobi J; Schlaich MP; Schneider M; Schmitz G; Schmieder RE
J Am Coll Cardiol; 2001 Apr; 37(5):1351-8. PubMed ID: 11300446
[TBL] [Abstract][Full Text] [Related]
7. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study.
John S; Schlaich M; Langenfeld M; Weihprecht H; Schmitz G; Weidinger G; Schmieder RE
Circulation; 1998 Jul; 98(3):211-6. PubMed ID: 9697820
[TBL] [Abstract][Full Text] [Related]
8. [Endothelial function and arterial hypertension].
Taddei S; Virdis A; Ghiadoni L; Salvetti A
Ann Ital Med Int; 1995 Oct; 10 Suppl():85S-90S. PubMed ID: 8562274
[TBL] [Abstract][Full Text] [Related]
9. Selective loss of microvascular endothelial function in human hypercholesterolemia.
Gilligan DM; Guetta V; Panza JA; García CE; Quyyumi AA; Cannon RO
Circulation; 1994 Jul; 90(1):35-41. PubMed ID: 8026018
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
Osto E; Matter CM; Kouroedov A; Malinski T; Bachschmid M; Camici GG; Kilic U; Stallmach T; Boren J; Iliceto S; Lüscher TF; Cosentino F
Circulation; 2008 Nov; 118(20):2073-80. PubMed ID: 18955669
[TBL] [Abstract][Full Text] [Related]
11. Impaired Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Hypertensive Patients With Primary Hyperaldosteronemia: Role of 5,6,7,8-Tetrahydrobiopterin Oxidation and Endothelial Nitric Oxide Synthase Uncoupling.
Chen L; Ding ML; Wu F; He W; Li J; Zhang XY; Xie WL; Duan SZ; Xia WH; Tao J
Hypertension; 2016 Feb; 67(2):430-9. PubMed ID: 26628675
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction in hypertension.
Puddu P; Puddu GM; Zaca F; Muscari A
Acta Cardiol; 2000 Aug; 55(4):221-32. PubMed ID: 11041120
[TBL] [Abstract][Full Text] [Related]
13. Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension.
Liu L; Liu J; Huang Y
J Cardiovasc Pharmacol; 2015 May; 65(5):399-405. PubMed ID: 25384196
[TBL] [Abstract][Full Text] [Related]
14. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion.
Harrison DG; Ohara Y
Am J Cardiol; 1995 Feb; 75(6):75B-81B. PubMed ID: 7863980
[TBL] [Abstract][Full Text] [Related]
15. Impairment of the nitric oxide-mediated vasodilator response to mental stress in hypertensive but not in hypercholesterolemic patients.
Cardillo C; Kilcoyne CM; Cannon RO; Panza JA
J Am Coll Cardiol; 1998 Nov; 32(5):1207-13. PubMed ID: 9809927
[TBL] [Abstract][Full Text] [Related]
16. Effect of simvastatin on the antihypertensive activity of losartan in hypertensive hypercholesterolemic animals and patients: role of nitric oxide, oxidative stress, and high-sensitivity C-reactive protein.
Abdel-Zaher AO; Elkoussi AE; Abudahab LH; Elbakry MH; Elsayed EA
Fundam Clin Pharmacol; 2014 Jun; 28(3):237-48. PubMed ID: 23488690
[TBL] [Abstract][Full Text] [Related]
17. Aerobic exercise training protects against endothelial dysfunction by increasing nitric oxide and hydrogen peroxide production in LDL receptor-deficient mice.
Guizoni DM; Dorighello GG; Oliveira HC; Delbin MA; Krieger MH; Davel AP
J Transl Med; 2016 Jul; 14(1):213. PubMed ID: 27435231
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide therapies in vascular diseases.
Kurowska EM
Curr Pharm Des; 2002; 8(3):155-66. PubMed ID: 11812265
[TBL] [Abstract][Full Text] [Related]
19. Is endothelial dysfunction reversible?
Schmieder RE; Schobel HP
Am J Cardiol; 1995 Jul; 76(2):117A-121A. PubMed ID: 7604785
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions.
Landmesser U; Hornig B; Drexler H
Semin Thromb Hemost; 2000; 26(5):529-37. PubMed ID: 11129409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
